page_banner

Products

4-Aminophenyl-β-D-galactopyranoside Cas:5094-33-7 Alba to Light Brown Pulvis 99%

Description:

Catalogue Number: XD90040
Cas: 5094-33-7
Formulae hypotheticae: C12H17NO6
Pondus hypotheticum: 271.27
Availability: In Stock
Pretium:
Prepack: 5g USD80
Mole Pack: Request Quote

Product Detail

Product Tags

Catalogue Number XD90040
Product Name 4-Aminophenyl-β-D-galactopyranoside
CAS 5094-33-7
Formulae hypotheticae C12H17NO6
M. Pondus 271.27
Repono Details Ambiens

Product Specification

Aspectus Alba ad lucem brunneis pulveris
Assay 99%
Repono Temp 0 - 8 °C
Density 1.517
FervensPoint 556 C
FlashPoint 290 C
RefractivusIndex -39.5 ° (C=1, H2O) ;

Mures una dosis plantae originis phenolicae antioxidantis Quercetin (QC) liberae, liposome encapsulatae et galactosylatae liposome encapsulatae formae 2 h administratae sunt ante dosem hepatotoxicum carbontetrachloridis (CCl4, 40% v/v in oleo olivarum, 1 ml/kg b .wt).Inter illas tres varias formas QC probatae, solum galactosylatum liposomale QC praebebat praesidium significantem contra CCl4 damnum oxidativum hepaticum inductum.Post 24 h injectiones (SC) cellulae hepaticae mures inventae sunt susceptibile ad CCl4 damnum oxidativum inductum et per auctam quantitatem dienae coniugatae in membrana hepatica monitore adhibita est.Duplex incrementum in diene coniugato per inductionem CCl4 usque ad gradum normalem per galactosylatum liposomale QC praetractatum diminutum est.Carbontetrachloride inducta membrana damna in cellulis hepaticis et a sanguine serum pathologico et hepatis examinatio histopathologica iudicata est.Membrana damnum inductione CCl4 prae- pensum erat ulteriori gradu membranae plasmatis (PM) ligatae enzyme Na+/K+ ATPase activitati et solum prae- curatione galactosylati liposomalis QC aucta erat.Carbontetrachlorida substantialis decrementum tam enzymaticum quam hypotheticum in cellulis hepaticis antioxidantibus endogenosis induxit. Depressione in systematis antioxidantis in cellulis hepaticis omnino impeditus est a dose unius galactosylati lipsosomal QC ante curationis CCl4.Assumptio hepatis QC aestimata est post 2 h ponderis corporis micromol/kg (gravioris corporis micromol/kg) (formae liberae vel liposomalis) et 85% injecti QC in iecore inventa est in casu galactosylato liposomali QC.Cum tantum 25% of dosis injecti in hepate deprehensa est, cum eadem copia liberi QC injecta est.Carbontetrachloride etiam mutationem fluiditatis in membrana induxit et per diminutionem in membrana parvae viscositatis aestimata est.Liber QC praecuratio prae- curationis in nullo praesidio contra CCl4 inducta aucta fluiditatis membranae hepaticae, cum galactosilata liposomalis QC praesidio notabili contra incrementum elaboravit.Proventus huius studii revelavit QC in liposome galactosylato notabilem tutelam contra CCl4 hepatocellulares iniuriam exercere posse.


  • Previous:
  • Deinde:

  • Close

    4-Aminophenyl-β-D-galactopyranoside Cas:5094-33-7 Alba to Light Brown Pulvis 99%